Matthew C Foster
5PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 25, 2025
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years.Eric D Eisenmann, Ronan Swords, Ying Huang
|Oct 31, 2022
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates.Antoine N Saliba, Scott H Kaufmann, Eytan M Stein
|Nov 15, 2021
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.Joshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova
|Feb 24, 2021
Utility of a safety switch to abrogate CD19.CAR T-cell-associated neurotoxicity.Matthew C Foster, Barbara Savoldo, Winnie Lau
|Sep 11, 2019
Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier.Christian P Bradley, Cai Chen, Karolyn A Oetjen
Pageof 1
Frequent Collaborators
2 joint publications
Joshua Zeidner
2 joint publications
Brian J Druker
2 joint publications
Alice S Mims
1 joint publications
Cheng Yan
1 joint publications
Nathan D Montgomery
1 joint publications
Richard J Gibbons
1 joint publications
Sharyn D Baker
1 joint publications
Natalie Grover
1 joint publications
Robert S Hagan
1 joint publications
Jonathan Serody
